Susquehanna International Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-26,679
| Closed | -$105K | – | 13962 |
|
|
2023
Q3 | $105K | Buy |
+26,679
| New | +$182K | ﹤0.01% | 10872 |
|
|
2023
Q2 | – | Sell |
-9,205
| Closed | -$33.3K | – | 13794 |
|
|
2023
Q1 | $33.3K | Buy |
9,205
+1,902
| +26% | +$29.4K | ﹤0.01% | 11871 |
|
|
2022
Q4 | $235K | Buy |
7,303
+6,404
| +712% | +$254K | ﹤0.01% | 9721 |
|
|
2022
Q3 | $38K | Buy |
+899
| New | +$41.1K | ﹤0.01% | 12361 |
|
|
2022
Q2 | – | Sell |
-10,138
| Closed | -$470K | – | 14667 |
|
|
2022
Q1 | $687K | Buy |
+10,138
| New | +$844K | ﹤0.01% | 8133 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 14506 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 14149 |
|
|
2021
Q2 | – | Sell |
-1,724
| Closed | -$435K | – | 13737 |
|
|
2021
Q1 | $369K | Buy |
+1,724
| New | +$477K | ﹤0.01% | 10165 |
|
|
2020
Q4 | – | Sell |
-593
| Closed | -$62K | – | 12119 |
|
|
2020
Q3 | $62K | Buy |
+593
| New | +$54K | ﹤0.01% | 10142 |
|
